Source comparison
TA-1 Same as Thymosin Alpha-1: Clinical vs Research-Grade Specifications
Research-grade TA-1 and clinical-grade thymosin alpha-1 (marketed as Zadaxin in some jurisdictions) are molecularly identical but differ in manufacturing oversight, endotoxin limits, and stability testing. Clinical-grade product undergoes GMP (good manufacturi
This comparison does not assign a generated winner or score.
- Research-grade TA-1 and clinical-grade thymosin alpha-1 (marketed as Zadaxin in some jurisdictions) are molecularly identical but differ in manufacturing oversight, endotoxin limits, and stability testing. Clinical-grade product undergoes GMP (good manufacturing practice) production with batch release testing for sterility, pyrogenicity, and potency. Regulatory thresholds require <0.5 EU/mg endotoxin and >95% acetylated content. Research-grade TA-1 sold for laboratory use is not subject to these release criteria; purity may be equivalent, but documentation and traceability standards are lower.
- This distinction matters for anyone considering transition from research to preclinical models: a peptide batch suitable for in vitro T-cell assays may contain endotoxin levels that trigger non-specific immune activation in vivo, confounding results. Research published using clinical-grade Zadaxin cannot be directly replicated with research-grade TA-1 unless endotoxin content is verified below clinical thresholds. We recommend labs conducting animal studies request endotoxin testing on every batch. The cost ($200–400 per LAL assay) is negligible compared to the risk of attributing observed immune effects to TA-1 when they're actually LPS-driven artifacts.
- The final specification difference is stability data: clinical-grade thymosin alpha-1 includes accelerated degradation studies showing degradation kinetics at 25°C, 37°C, and 40°C over 6–12 months. Research-grade suppliers rarely provide this data, meaning storage recommendations ('store at −20°C') are assumptions, not validated conditions. TA-1 degrades primarily through methionine oxidation and asparagine deamidation. Both reactions accelerate exponentially above 8°C. A vial left at room temperature for 48 hours may show no visible change but lose 20–30% potency. Reconstituted TA-1 in bacteriostatic water at pH 6.5–7.5 shows <5% degradation over 14 days at 2–8°C; at room temperature, degradation exceeds 15% within 72 hours.